From Cancer to COVID, Boston to Beirut.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33735513.
- Also identified by DOI 10.1002/cncr.33538 and PMC identifier 8250751.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The COVID‐19 pandemic has highlighted health and vaccine disparities. Lessons from the collaborative development of targeted therapies for lung cancer and their impact on survival show that there is a better path forward.
Medical subject headings
- COVID-19
- COVID-19 Vaccines
- Mass Vaccination